Related Experiment Video
Updated: Aug 16, 2026

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection
Published on: February 19, 2019
Fibrosis progression in chronic hepatitis C patients with occult hepatitis B co-infection
Chee-Kin Hui1, Eva Lau, Helen Wu
1Department of Medicine, The University of Hong Kong, Hong Kong SAR, China. ckhui23@gmail.com
Insights
Occult hepatitis B virus (HBV) infection in hepatitis C virus (HCV) patients does not appear to accelerate liver fibrosis progression. Further large-scale studies are needed to confirm this finding regarding HBV/HCV co-infection.
Area of Science:
- Hepatology
- Virology
- Gastroenterology
Background:
- Occult hepatitis B virus (HBV) infection, defined by detectable HBV DNA without hepatitis B surface antigen (HBsAg), can coexist with hepatitis C virus (HCV) infection.
- The impact of occult HBV infection on liver fibrosis progression in patients with chronic HCV remains unclear.
Purpose of the Study:
- To investigate the association between occult HBV infection and the rate of liver fibrosis progression in patients with chronic HCV infection.
- To compare the incidence of fibrosis progression and development of severe fibrosis (stages 3-4) in HCV patients with and without occult HBV infection.
Main Methods:
- Retrospective analysis of 74 consecutive anti-HCV positive patients.
- Diagnosis of occult HBV infection via serum HBV DNA detection using PCR.
- Assessment of liver fibrosis progression using serial liver biopsies (median 2 per patient) over a median follow-up of 57.7 months.
Main Results:
- 31 patients (41.9%) were diagnosed with occult HBV infection.
- Fibrosis progression occurred in 35.5% of patients with occult HBV infection versus 27.9% without (p=0.608).
- Progression to severe fibrosis (stage 3-4) was observed in 19.4% with occult HBV infection versus 18.6% without (p=0.946).
Conclusions:
- Occult HBV co-infection in chronic HCV patients does not appear to significantly alter the rate of liver fibrosis progression or the development of severe fibrosis.
- Larger, prospective studies are warranted to definitively establish the role of occult HBV infection in HCV-related liver disease progression.
Abstract:
Occult hepatitis B virus (HBV) infection in individuals without hepatitis B surface antigen (HBsAg) can be identified in hepatitis C virus (HCV) infected patients. However, its role in fibrosis progression remains uncertain. This retrospective study compared the fibrosis progression (defined as fibrosis progression by at least one stage) and progression to severe fibrosis (fibrosis stage 3 or 4) in HCV patients with occult HBV infection. Occult HBV infection was diagnosed by the detection of HBV DNA in the serum of 74 consecutive anti-HCV positive patients by PCR. Thirty-one patients (41.9%) had occult HBV infection. All 74 patients had a median of 2 (range 2-3) liver biopsies. The median time between the first and last liver biopsy was 57.7 (range 15.0-132.8) months. Eleven of the 31 patients with occult HBV infection compared with 12 of the 43 patients without occult HBV infection had fibrosis progression (35.5% versus 27.9%, respectively, p=0.608). Six of the 31 patients with occult HBV infection compared with 8 of the 43 patients without occult HBV infection developed severe fibrosis (19.4% versus 18.6%, respectively, p=0.946). In conclusion, chronic HCV patients with occult HBV co-infection does not seem to progress more than patients without occult HBV infection. However, more large-scale studies are needed before a definite conclusion can be obtained.
Related Concept Videos
Cirrhosis II: Pathophysiology
Cirrhosis I: Introduction
Hepatitis
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Chronic Pancreatitis II: Pathophysiology
Viral Hepatitis I: Introduction
